Table 1.
Meta-analysis | Studies evaluated (n) | Diabetes duration (yr) | Risk | 95%CI | |
Everhart et al[76] | 20 | All studies evaluated | > 1 | RR = 2.1 | 1.6-2.8 |
11 | All case-control studies | > 1 | RR = 1.8 | 1.1-2.7 | |
9 | All cohort studies | > 1 | RR = 2.6 | 1.6-4.1 | |
11 | All studies | > 5 | RR = 2.0 | 1.2-3.2 | |
6 | All case-control studies | > 5 | RR = 1.8 | 0.86-3.8 | |
6 | All cohort studies | > 5 | RR = 2.4 | 0.85-7.0 | |
Li et al[64] | 3 | ≤ 2 | OR = 2.9 | 2.1-3.9 | |
3 | 3-5 | OR = 1.9 | 1.3-2.6 | ||
3 | 6-10 | OR = 1.6 | 1.2-2.3 | ||
11-15 | OR = 1.3 | 0.9.2.0 | |||
> 15 | OR = 1.4 | 1.0-2.0 | |||
Huxley et al[80] | 9 | 1-4 | RR = 2.05 | 1.87-2.25 | |
9 | 5-9 | RR = 1.54 | 1.31-1.81 | ||
7 | ≥ 10 | RR = 1.51 | 1.16-1.96 | ||
Ben et al[84] | 3 | < 1 | RR = 5.38 | 3.49-8.30 | |
5 | 1-4 | RR = 1.95 | 1.65-2.31 | ||
4 | 5-9 | RR = 1.49 | 1.05-2.12 | ||
4 | ≥ 10 | RR = 1.47 | 0.94-2.31 |